Here you’ll find news articles and links to interesting resources/downloads about Hodgkins Lymphoma and other cancers.

Classical Hodgkin Lymphoma – What is it? The basics…

Found a very interesting page on the website which goes into great details on the basics of classical Hodgkin lymphoma (my condition) and its treatment, explaining: What is classical Hodgkin lymphoma? What causes classical Hodgkin lymphoma? What are the symptoms of classical Hodgkin lymphoma? How is classical Hodgkin lymphoma diagnosed? What does ‘stage’ mean?… Read more »

Steroids in the treatment of lymphoma

A very interesting article on Lymphoma Association website discussing corticosteroids commonly used during chemotherapy, their uses and side effects. Read the full article here

Gut microbes affect immunotherapy

The unleashing of antitumor T cell responses has ushered in a new era of cancer treatment. Although these therapies can cause dramatic tumor regressions in some patients, many patients inexplicably see no benefit. Read the full article here

Cannabis, cannabinoids and cancer – the evidence so far

Interesting article on Cancer Research UK website: Few topics spark as much debate on this blog and on our Facebook page than cannabis. So we thought we’d take a look at the common questions raised about the evidence and research into cannabis, cannabinoids (the active chemicals found in the plant and elsewhere) and cancer, and… Read more »

24 Reasons To Go & Pick Dandelions Right Now

The Health Benefits of Dandelions Dandelion has been used throughout history to treat everything from liver problems and kidney disease to heartburn and appendicitis. Every part of this common weed – from the roots to the blossoms – is edible. It’s a good thing too, as the humble dandelion is bursting with vitamins A, B,… Read more » – why haven’t we cured cancer yet?

Interesting article from on the reasons why cancer hasn’t been ‘cured’ yet: Why haven’t we cured cancer yet? If we can put a man on the moon, why can’t we cure cancer? If we can harness the atom, why can’t we cure cancer? How many times have you heard these questions, or variants thereof?… Read more »

EMA Action Brings Nivolumab Closer to First Hematology Approval

The European Medicines Agency (EMA) validated an application for use of nivolumab (Opdivo) for previously treated patients with classical Hodgkin lymphoma (cHL), which officially begins the centralized review process for final approval of the drug in the European Union (EU). The EMA will be evaluating nivolumab primarily based on data from the phase II CheckMate-205… Read more »